Clinical Trials Directory

Trials / Sponsors / Gates Medical Research Institute

Gates Medical Research Institute

Academic / Other · 17 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingBactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in
Drug Susceptible Pulmonary Tuberculosis
Phase 22026-04-13
Not Yet RecruitingBactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis
Drug Susceptible Pulmonary Tuberculosis
Phase 22026-04-10
CompletedA Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBD09
Healthy Adult Participants
Phase 12025-09-03
RecruitingStudy To Evaluate Safety, Tolerability, and Pharmacokinetics of MAM01 in African Population
Healthy Volunteers
Phase 12025-03-28
CompletedA Trial in Healthy Adult Participants to Evaluate the Safety, Tolerability, and Behavior in the Body of TBD11
Healthy Adult Participants
Phase 12024-12-05
Active Not RecruitingStudy to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and
Tuberculosis
Phase 32024-03-05
CompletedSafety, Tolerability, Pharmacokinetics and Protective Efficacy of MAM01 in Healthy Adults
Malaria
Phase 12023-08-14
TerminatedEfficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PB
Pulmonary Tuberculosis
Phase 22023-07-26
TerminatedImpact of Bi-26 Supplementation on Weight Gain in Underweight Infants
Underweight, Paediatrics
Phase 32023-07-03
CompletedSafety, Tolerability, Pharmacokinetics (PK), and Food Effect of MK-7762 in Healthy Adults
Tuberculosis
Phase 12023-02-23
WithdrawnProof of Concept Trial of Adjuvant Activity of SWE, a Squalene-based -Oil-in-water Emulsion
Influenza
Phase 12022-07-14
CompletedEpidemiologic Study to Assess the IGRA Positivity in Populations With a High TB Burden
Tuberculosis, Pulmonary
—2021-12-20
CompletedSafety, Tolerability, and Pharmacokinetics of RSV Monoclonal Antibody RSM01 in Healthy Adults
RSV Infection
Phase 12021-11-16
CompletedSafety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine M72/AS01E in Participants With Well-controll
Human Immunodeficiency Virus
Phase 22020-11-17
TerminatedA Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19)
COVID-19
Phase 22020-09-02
CompletedEarly Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis
Pulmonary Tuberculosis
Phase 22020-01-16
TerminatedBacille Calmette Guerin (BCG) Revaccination of Healthy Adolescents for the Prevention of Mycobacterium Tubercu
Tuberculosis
Phase 22019-10-16